Vlad Zaha is a Cardiology physician affiliated with Parkland Health & Hospital System. OpenAlex indexes 168 publications with 5,012 citations (h-index 31); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2001 Inwood Rd Fl 5
Dallas, TX 75390
Telephone
214-645-8000Registry record last updated 10 Jun 2019.
Clinical trials
- Using Hyperpolarized [1-13C]Pyruvate to Detect Cardiotoxicity
Sponsor: University of Texas Southwestern Medical Center
- UTSW HP [13-C] Pyruvate Injection in HCM
Sponsor: University of Texas Southwestern Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Siemens Medical Solutions USA, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
87.9%Statin27.7%Rosuvastatin Calcium83%Atorvastatin Calcium17%Part D≥113 patientsBeta blocker13.3%Carvedilol50%Bisoprolol Fumarate26%Nebivolol Hcl15%Metoprolol Succinate10%Part D<11 patients+ 11 more classes in this area
Metabolism & gastrointestinal
9.8%SGLT2 inhibitor9.8%Jardiance87%Farxiga13%Part D<11 patientsBlood & clotting
2.3%Factor Xa inhibitor2.3%Eliquis100%Part D≥13 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Immune Checkpoint Inhibitor Myocarditis and Left Ventricular Systolic Dysfunction
JACC CardioOncology
2025 - Consensus recommendations for hyperpolarized [1‐ <scp> <sup>13</sup> C </scp> ]pyruvate <scp>MRI</scp> multi‐center human studies
Magnetic Resonance in Medicine
2025 - NCCN Guidelines® Insights: Management of Immunotherapy-Related Toxicities, Version 2.2024
Journal of the National Comprehensive Cancer Network
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Darren McGuire, MD
Parkland Health & Hospital System
Adam Yopp, MD
Parkland Health & Hospital System
Andreas Reimold, MD
Parkland Health & Hospital System
Luigi Meneghini, MD
Parkland Health & Hospital System
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”